October 27, 2020 COVID-19 : monitoring the outbreak progression Since the very early days of COVID-19 outbreak in Belgium, DNAlytics has been working with academic experts and public authorities towards objective, data-driven public health policies. Partners The project has… READ MORE
October 27, 2020 COVID-19 : mastering the risk of contagion Since the very early days of COVID-19 outbreak in Belgium, DNAlytics has been working with academic experts and public authorities towards objective, data-driven public health policies. This second set of… READ MORE
February 5, 2019 Management of severe food allergies Partner DBV Technologies is a global clinical stage biopharmaceutical company developing a novel class of immunotherapy against food allergies. Their investigational treatment portfolio is built over Viaskin® platform, a… READ MORE
November 27, 2018 Pathogenic mutations in G-6-PD gene Partner ZenTech is a Belgian biotech company specialized in the diagnosis of pathologies arising in the early life stages. ZenTech develops, produces and sales immunoassay screening IVD kits based… READ MORE
October 23, 2018 Identification of biomarkers for innovative oncology prodrug Partner Convert Pharmaceuticals is a preclinical-stage company that builds a proprietary drug pipeline exploiting specific actors of the tumor micro-environment or therapeutic benefit. Convert’s lead product CP-506 is a hypoxia-activated… READ MORE